The leaders of Japan and China got off to a tense start but have made significant progress in turning around their relations in recent years.Asia Politicsread more
Tech's hottest IPOs of the year, including Beyond Meat and Zoom, dropped on Monday, falling more than the broader market.Technologyread more
Stocks in Asia slipped in Tuesday afternoon trade, while investors looked toward a meeting between U.S. President Donald Trump and Chinese President Xi Jinping set to happen...Asia Marketsread more
A week of dovish fireworks out of the central banking community has just gone by with most of the world's leading central banks now guiding towards easing in light of downside...Commentaryread more
"We do not seek conflict with Iran or any other country," Trump tells reporters in the Oval Office.Politicsread more
Chinese Vice Premier Liu He held a phone conversation with U.S. Trade Representative Robert Lighthizer and U.S. Treasury Secretary Steven Mnuchin, China's Ministry of Commerce...World Economyread more
Sen. Bernie Sanders announced a plan Monday to forgive the country's $1.6 trillion outstanding student loan tab, intensifying the higher education policy debate in the 2020...Personal Financeread more
While earnings usually come in substantially ahead of expectations — as much as 4 or 5 percentage points is not unusual — the downward direction in the outlook doesn't speak...Earningsread more
U.S. President Donald Trump's senior adviser Kellyanne Conway will not testify before the House of Representatives Oversight Committee this week on her alleged violations of...Politicsread more
"We missed being the dominant mobile operating system by a very tiny amount. We were distracted during our antitrust trial. We didn't assign the best people to do the work,"...Technologyread more
PatientsLikeMe was bought by UnitedHealth following a review by Trump's Treasury Department, which scrutinized the start-up because it's backed by Chinese cash.Technologyread more
Syndicates of Lloyd's of London insurance market filed a countersuit to Kanye West's claim that he was owed $10 million after canceling his tour last year, saying it found "substantial irregularities" in the rapper's medical history.
The counterclaim was filed in federal court in Los Angeles on Tuesday, saying West's Very Good Touring Inc had failed to cooperate in the insurance company's investigation into the claim for canceled concerts, according to the court documents.
Without going into details, Lloyd's also noted that its policies exclude any losses caused directly or indirectly by the possession or use of illegal drugs, the impact of prescription drugs not used as prescribed, or the use of alcohol.
The court documents said in order to protect West "from public disclosure of details of his private life," Lloyd's would not include specific information it had obtained in relation to the claim. Lloyd's did say the underwriters' investigation found "substantial irregularities in Mr. West's medical history."
West, 40, sued Lloyd's, an insurance market housing more than 80 syndicates in London, for nearly $10 million in insurance payouts after he abruptly canceled his Saint Pablo tour in November 2016 with more than 20 shows left.
The musician's lawsuit, filed in early August, said he was hospitalized with a "serious, debilitating medical condition," following a week of no-shows, curtailed concerts and on-stage political rants.
West's lawsuit said Lloyd's had suggested "they may deny coverage of the claim on the unsupportable contention that use of marijuana by Kanye caused the medical condition."
In its countersuit, Lloyd's said West's company and other representatives "have delayed, hindered, stalled and or refused to provide information both relevant and necessary for Underwriters to complete their investigation of the claim."
"Underwriters are informed and believe, and thereon these same persons have willfully concealed and or misrepresented relevant facts in an effort to thwart Underwriters' investigation," the counterclaim added.
West's lawyer, Howard E. King, said in a statement on Wednesday that Lloyd's did not "want to honor a legitimate claim but can't find a factual basis to deny a claim."
Lloyd's is seeking a jury trial. Representatives did not immediately return requests for comment.